Hamburg Edoxaban for Anticoagulation in COVID-19 Study
Clinical trial NCT04542408 · COMPLETED
Trial details
- NCT number
- NCT04542408
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2022-09-06
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.